chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately post injection severe stinging occurred. Three days later night sweats bodyaches low-grade fever diarrhea intense headache which lasted three weeks. Headache and bodyaches continued with night sweats for an additional two weeks.
Approximately 15 minutes after vaccine, patient states she felt 'unbalanced.' Upon assessment  patient is a&o x4, answering questions appropriately and does not appear to be altered. Describes sensation of feeling the room spinning when she stands up. patient has HX of Anxiety and states that she feels similar to her Anxiety and that she feels anxious at this time. Patient was taken to school nurse and parent called to pick up student.  Vitals taken; BP 127/74, HR 90
Pt has had flu-like symptoms for approximately 2 weeks post each vax. He has developed allergic conjunctivitis of 1 years duration, arthritis in both shoulders since starting vax series. In Dec 1998, When he received his first 3 anthrax vaxs, he had hot and cold sweats, shivering, fever (resolved 24-48 hours), lethargy, and body aches (resolved in approximately 2 weeks). Also bruising at injection site.  One month after starting series, arthritic symptoms appeared and continue in left shoulder (aching and stiff). Post 4th vax, arthritic symptoms appeared in right shoulder and continue to present.  05/06/99 Seen by Ophthalmology for chronic conjunctivitis. 08/19 seen by civilian allergist. Dx with perennial allergic rhinitis, possible vasomotor rhinitis, and allergic conjunctivitis. 09/09 seen by civilian allergist. Skin testing showed positive reactions to mesquite, lamb's quarters, and Russian thistle, which did not correlate to symptoms. Revised diagnosis of vasomotor rhinitis. Treatment is symptomatic only. 09/21 seen by Flight Surgeon for rash. Dx with probable allergic dermatitis. 09/23 seen by Flight Surgeon for rash. Dx with possible tinea corporis. Lesions biopsied, revealed perivascular dermatitis. 01/19/2000 reviewed by flight surgeon for return to flying status.
Information has been received on 2/25/02 from an RN concerning a 17 year old female with no past medical history who was vaccinated with a series of Hep-A virus vaccine inactivated, from a recalled lot (lot 1151C-invalid). There was no concomitant medication. Subsequently, the pt's antibody titer was found to be negative. It was reported that the pt was to be revaccinated with 2 doses. Additional information has been requested. A 15-day follow up report received 6/3/2003 adds: It was reported that the "vaccine needs to be re-administered". There were no adverse reactions. Unspecified medical attention was sought. No further info is available.
arm was hurting; Hard lump at the injection site; Injection site was itching; red spot at the injection site; Injection site muscle ached; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was hurting), VACCINATION SITE INDURATION (Hard lump at the injection site), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE PAIN (Injection site muscle ached) and VACCINATION SITE ERYTHEMA (red spot at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0391Z20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION SITE PAIN (Injection site muscle ached). On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm was hurting), VACCINATION SITE INDURATION (Hard lump at the injection site), VACCINATION SITE PRURITUS (Injection site was itching) and VACCINATION SITE ERYTHEMA (red spot at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) on 14-Jan-2021 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was hurting), VACCINATION SITE INDURATION (Hard lump at the injection site), VACCINATION SITE PRURITUS (Injection site was itching), VACCINATION SITE PAIN (Injection site muscle ached) and VACCINATION SITE ERYTHEMA (red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient noted to have a hive at injection site where MMR given. He was immediately given Benadryl and stayed for 1 hour. The hive disappeared.
I became  very dizzy when I would move my head and neck toward the left side- it has since steadily decreased - dizziness almost gone now/ never had that before
10 minutes post-administration, patient developed itchy rash on right cheek.; Symptoms include itching, burning, and tingling at rash site/ Itching worsened and spread throughout body; Symptoms include itching, burning, and tingling at rash site.; Symptoms include itching, burning, and tingling at rash site.; Patient was also thirsty (was given water).; feverish; dizzy; Itching started in mouth; began to feel shaky and still feeling dizzy; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported for a 67-year-old (non-pregnant) female patient who received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: EL3247) intramuscularly into the left arm on 28Jan2021 (at the age of 67-year-old) as first dose single for COVID-19 immunization. The patient medical history included hypertension, hypothyroid and known allergies to Aspirin, Codeine, Tolyn, Compazine, Nubain, Reglan, Toradol, Vicodin, morphine and Dilaudid at an unspecified date. Concomitant medications included Lisinopril, gabapentin, Ambien, Synthroid on an unspecified date. On an unspecified date, the patient had COVID prior vaccination and not tested post vaccination. On 28Jan2021, ten minutes post-administration, the patient developed itchy rash on right cheek. Symptoms included itching, burning and tingling at rash site. Patient was also thirsty (was given water). Benadryl oral was given. Symptoms were not resolving and patient began to feel feverish and dizzy. Itching worsened and spread throughout body. Dexamethasone oral was given. Itching started in mouth. EpiPen was administered intramuscularly to left vastus lateralis. Hypertension was seen. Itching in mouth subsided 15 minutes post EpiPen, but patient began to feel shaky and still feeling dizzy. The patient underwent lab tests which included body temperature as feverish on 28Jan2021. Monitored for additional 20 minutes. After, patient was stable and walked out via wheelchair enroute home. No other vaccines in four weeks. Treatment was received with Benadryl, dexamethasone, EpiPen. The outcome of the events were recovering.  Follow-up attempts are completed. No further information is expected.
humming of my ears and head and that is really scaring me; ''because'' of distance it sounds like air conditioner or something; I am really nervous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset Nov2021, outcome "unknown", described as "humming of my ears and head and that is really scaring me; ''because'' of distance it sounds like air conditioner or something"; NERVOUSNESS (non-serious) with onset Nov2021, outcome "unknown", described as "I am really nervous".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Additional information: When paraphrased the concern, consumer stated, " Yes, a humming kind of a (incomplete sentence), 'because' of distance it sounds like air conditioner or something and it is really scary and it started up after I had the booster vaccination, Pfizer booster."
INJECTION SITE PAIN FOR 10 MINUTES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced injection site pain for 10 minutes. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain for 10 minutes. This report was non-serious.
Patient became light headed, nauseous, flushing, hives and tingling of lips and tongue.
stringy yellow bowel movement. Whining and straining. Fever 101.4. Fussy and gassy.
Male patient 31 year old reports after getting his first dose PRIZER on August 30, 2021 he felt a burning and stinging in his left arm in the area where he was vaccinated and a water bubble was formed. September 1, 2021 patient went to the doctor and was prescribed antibiotics and tripe antibiotics for the affected area.
Child fainted as 3rd vaccine was being administered. Used ammonia inhalent. Child responded quickly. No other symptoms presented. Child left the office at 12:40 PM.
A report has been received from a Health Professional concerning a 5 year old, Male subject, who had been receiving Nasal FLUMIST. FLUMIST started on 29-Sep-2012. The patient experienced POSITIVE FOR INFLUENZA A which started on 31-Dec-2012. The outcome of the event of POSITIVE FOR INFLUENZA A is unknown. The report was considered to be non-serious.
tired, body  muscle weakness, trouble walking, hands and legs numb and cold, pins and needles
BOTH HANDS GOT BEET RED AND SKIN AROUND MOUTH ITCHES STARTING AT 9PM.  TOOK 1 BENADRYL AT 9PM AND HANDS WENT BACK TO NORMAL AND MOUTH SKIN NO LONGER ITCHES.  WARNED TO CALL EMS IF ANY MORE ISSUES.
Pt states that when given the vaccine that she "involuntarily jumped off the chair." She has had range of motion issues since then and continues to have these issues.  She has seen a massage therapist, chiropracter and now is making an appointment with an othopedist
Within 2 hours of receiving the injection, ears felt clogged and significant whooshing noise and popping. The whooshing noise eventually deceased and ringing in the ears began later that day and has not ceased.
Woke up the morning after getting the booster and had 40 or so petechiae spots on my left forearm, and 10 - 15 on my Right forearm.  Since then the number has reduced by about half.  On February 8th my husband tested positive for covid.  On 2/10/2023 I started feeling sick, and tested positive as well.  When I woke up the next morning, most of the petechiae spots on my left arm had broken open and had scabs.  I still have a few (5) minor scabs, and still have around 20 spots on my left arm an d 6 or 7 on my right arms
Mom states fever up to 102 deg F w/crying, fussiness on/off all the evening of vaccine administration and the next day.
Body aches, fever, swelling and red at injection site(5x3) raised whelp
fever over 100 for 3 days, dizziness from 7/24/21 to present- meclizine
Patient received wrong dose of covid vaccine booster. Vial was diluted by staff, should not have been diluted.
Patient received second dose of Pfizer vaccine and patient was nervous about needles.  Patient felt nauseas after the vaccine and had to be brought down on floor.  Patient felt little numb in hands but was breathing fine.  Had to call 911. Patient's vitals were good however his blood sugar was low.
20 minutes p/recvd 1st dose of Engerix-B devel diuresis, inc heart rate &  nausea; pt recovered quickly;
Tested positive for Covid-19/had symptoms; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid-19/had symptoms) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022T21A) for COVID-19 prophylaxis.     No other vaccines was given within 1 month prior to Moderna COVID-19 vaccine.  Previously administered products included for COVID-19 prophylaxis: J and J (1st Dose-J and J but did not like the " whole clotting"). Past adverse reactions to the above products included Clot blood with J and J. Concurrent medical conditions included Penicillin allergy and Blood pressure high (Blood pressure spikes up when was stressed. So a low dose Lisinopril 10mg once a day was given). Concomitant products included LISINOPRIL for Blood pressure high.    On 22-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Aug-2022, the patient experienced COVID-19 (tested positive for Covid-19/had symptoms). At the time of the report, COVID-19 (tested positive for Covid-19/had symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Aug-2022, SARS-CoV-1 test: (Positive) Positive. On 06-Sep-2022, SARS-CoV-1 test: (Negative) Negative.         The patient tested positive for COVID-19 on 27-AUG-2022, a week after he was due to 2nd Moderna booster dose. The patient had symptoms then and again tested negative on 06-Sep or 07-Sep-2022. The patient's height was not asked. The treatment medication was not reported.
Moderna COVID Vaccine: COVID-19 case resulting in Hospitalization / Death. Received Moderna Vaccine on 2/23/21 and 3/23/21. Presented to ED 2/9/22 c/o increasing SOB. Temp 99.5°, HR 84, RR 30, saturating 69% initially w/non-rebreather up to mid 90s on 60 L/70% high-flow nasal cannula. Admitted for acute hypoxic respiratory failure due to COVID-19. CTA PTE protocol without evidence of PTE but consistent with multifocal Covid PNA. Given 2 units of platelets for low plt count. Repeat x-ray 02/19 showed worsening PNA. Clinical condition progressively worsened, transitioned to comfort care only, expired 2/21/22. Tx'd with vancomycin, cefepime, cefdinir,  remdesivir, dexamethasone.
MenB (BEXSERO) administered to a 14 year old who does not fit any of the criteria to obtain it before the age of 16.
She was transferred to the hospital on 3/4/2021 due to low blood pressure, she understands that due to heart failure.  The death certification information is unknown.
PATIENT SAYS THEY HAD RED EYES THE NEXT DAY AFTER FLU SHOT
CDC Reports: 2 mo infant received DTP/OPV on 11DEC89 and died 15DEC89.
HEADACHE; FEVER; This spontaneous report received from a parent concerned a 28 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, non alcohol user, and non smoker, and other pre-existing medical conditions included patient had no known allergies or drug abuse illicit allergy.. The Patient had reported no lingering effect. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 on left deltoid at 14:30 hours for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced headache. On 09-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101.8 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from headache, and fever on 10-MAR-2021. This report was non-serious.
patient noted dizziness right after vaccine, abated in 30 min, had HA next day, which improved. Since vaccine intermittent dizziness and palpitations which come and go. No rash or swelling  I am not sure if from vaccine or anxiety related, but I wanted to report
Mom brought pt to MD 22AUG91 reporting that pt became listless & difficult to wake around 430PM on 21AUG91; Md reports this was not a long lasting event; Md reports hypoactive/hyporesponsive episode p/DTP#1; recommend no further DTP;
Patient had a syncopal episode following administration of vaccines. Mother stated this has happened in the past after vaccines were given today.
I63.522 ACUTE STROKE DUE TO OCCLUSION OF LEFT ANTERIOR CEREBRAL ARTERY 4/19/2023 BPH (BENIGN PROSTATIC HYPERPLASIA)
Headache SORE ARM AT INJECTION SITE. FATIGUE AND HEADACHE THAT LASTED 48 HOURS Narrative:
Presented with red macular patechy rash most concentrated on face, also over trunk and diaper area, blanches easily.
I experienced dizziness with spinning, I had to sit down. While sleeping at night I had dreaming of spinning and woke up dizzy. I went to the doctor and was told it was vertigo. They informed me of exercises for vertigo. I was prescribed medications. The vertigo cleared approximately 3 days later.
male with medical comorbidities including metastatic non-small cell lung cancer (diagnosed in 2/2021, endobronchial stent placed in left lung,  on alectinib since 4/2021 and s/p palliative radiation of mediastinum, hypertension, PE found on 2/21/2021 on Eliquis, COVID-19 diagnosed on 08/30/2021 presenting with progressive shortness of breath.   Patient's symptoms began on 08/27 with nonproductive cough, dyspnea on exertion, and fatigue.  He presented to the ED for the symptoms on 08/30 where he tested positive for COVID-19, he had been vaccinated prior.
ARMS WERE STILL HURTING; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported.  On an unspecified date, the patient experienced arms were still hurting. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from arms were still hurting. This report was non-serious.
pt devel sx of measles w/Koplik's spots following vax w/MMR vax; no further details were provided;
pt recv vax 19AUG98 & 21AUG98 pt came down w/full blown case of chicken pox w/low grade temp;pox & low grade temp still presents as of 3SEP98
Patient received 2nd dose in Moderna COVID19 vaccine series late as per FDA EUA/Manufacture guidance.  Original dose in series received on 1/18/21 from another agency (102 days between doses)
Employee had gone for routine physical and blood work and CBC showed a low platelet count of 45. Has followed by hematologist and suspicion of reaction to flu vaccination. Reviewed CBC results annually from 3/21/2011 - 4/18/2014 and Platelets were between 186-224 range. Had received flu vaccine in the past 2010-2013 received thimerosal-free without any problem. 2014 received a regular flu vaccine on 9/23/2014, however her CBC record in 2014 was from 4/18/2014 that showed normal platelets. CBC was done prior to the flu vaccination in 2014.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  The vaccine was placed into the freezer the same day they were delivered. The facility only removed a vial from the freezer and put it in the refrigerator the day before it was used. Thus the vaccines were not in the fridge for more than a day unless patients did not appear for their vaccine. The facility did not have a vial stay in the refrigerator for more than a week, since all unused vials were utilized for the patients.   This case was linked to MOD21-167637, CMOD21-00647 (E2B Linked Report).; Sender's Comments:  MOD21-167637:
FOUR HRS AFTER FIRST DOSE OF HEP B VAX, PT EXP FEVER, CHILLS, NAUSEA. EXP HEADACHE ONE DAY AFTER ADMIN OF VAX. FOR THE FOLLOWING 2 WEEKS SHE DEVELPD SEVERE UPPER RESP INFECTION /W/ SEVERE SWOLLEN GLANDS. NO TREATMENT GIVEN. SYMPTOMS ABATED.
TRANSIENT BLURRED VISION, NAUSEA, HA, BODY ACHES, LOSS OF APPETITE AND DIARRHEA
soreness on arm where shot was administered; heart palpitations; difficulty in eating; difficulty in sleeping; Concomitant drugs: INFLUENZA VIRUS (influenza immunisation); Concomitant drugs: INFLUENZA VIRUS (influenza immunisation); This is a spontaneous report from a contactable consumer, the patient. An 85-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose number 1, via an unspecified route of administration in the left arm on 11Jan2021 at 12:00 (at the age of 85-years-old) as a single dose for COVID-19 vaccination. Medical history included high blood pressure from an unknown date and unknown if ongoing. Concomitant medication included influenza vaccine (FLU), hydrochlorothiazide, losartan potassium (HYZAAR) and metoprolol succinate (TOPROL XL). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient reported having received the flu vaccine within 4 weeks prior to the Covid-19 vaccine. The patient did not have any allergies to medications, food, or other products. On an unspecified date in Jan2021, the patient experienced soreness in the arm where the shot was administered; and Concomitant drugs: INFLUENZA VIRUS (influenza immunisation). She took ibuprofen (ADVIL) for the soreness. In approximately 49 hours, the patient experienced heart palpitations that lasted about 24 hours, leading to difficulty in eating and sleeping. The clinical outcome of the soreness in the arm where the shot was administered, heart palpitations, difficulty eating and difficulty sleeping. The clinical outcome of Concomitant drugs: INFLUENZA VIRUS (influenza immunisation) was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.